IRIDEX
Company   Investors   Events   News   Careers   Search
Sales: 
Support: (800) 388-4747
  • Home
  • Products
    • Lasers
      • IQ 532™
      • IQ 577™
      • IQ 810™
      • Additional Lasers
    • Delivery Devices
    • Retina Consumables
      • EndoProbe Handpieces
      • Consumables
      • DioPexy™ Probe
    • Glaucoma Consumables
    • Veterinary
    • ENT
  • MicroPulse™
  • Physician Education
    • Glaucoma
      • TSCPC G-Probe
      • Trabeculoplasty (MLT)
    • Retina
      • Central Serous Chorioretinopathy
      • Diabetic Macular Edema
      • ME due to RVOs
      • Vitreoretinal Surgery
    • Clinical Library
  • Patient Education
    • Treat My DME
    • Treat My Glaucoma
  • Contact
    • Contact Us
    • Ask A Question
    • Schedule A Demo
    • Request A Quote
    • Order EndoProbe®
    • International Distributors
HOME > Physician Education > Retina > Diabetic Macular Edema

Diabetic Macular Edema

Learn How To Treat Diabetic Macular Edema (DME) with MicroPulse™ Laser Therapy

Diabetic Macular Edema

 

  • Solutions
  • Webinars
  • Videos
  • Clinical
  • Testimonials
577 Laser

IQ 577™ laser

PRODUCT HIGHLIGHTS

  • Repeatable retinal therapeutic capabilities: macular and foveal
  • Success with refractory and sub-clinical edema


Schedule Demo

 

 

 

 

Integration of MicroPulse Laser Therapy in the Management of Diabetic Retinopathy

Sam E. Mansour

 

 

Principles of Subthreshold MicroPulse Laser Therapy for Retinal Disorders

Marco Zarbin, MD, PhD, FACS
Martin Flores-Aguilar, MD
Timothy Murray, MD, MBA, FACS
Stela Vujosevic, MD

 

 

The Retina Safety Profile of Subthreshold MicroPulse Laser for Center Involving DME: 810 nm vs 577 nm Wavelength

Edoardo Midena, MD, PhD (C), FACS

 

 

The Versatility of MicroPulse Therapy: Current Clinical Applications and Research

Sam Mansour, MD, FRCS (C), FACS

 

 

MicroPulse Laser: Anterior to Posterior Segment

David Gossage, DO, FAOCO, FAAO
Hillsdale, MI

 

 

532 nm MicroPulse Laser Therapy: Clinical and Business Considerations for the Comprehensive Ophthalmologist

David Dickman, MD

 

 

How to Determine MicroPulse™ Laser Parameters for Sub-Visible-Threshold Treatments

Giorgio Dorin

 

 

 

 

577 nm MicroPulsed Central Laser Stimulation for Diabetic Macular Edema

José Augusto Cardillo, MD
São Paulo, SP, Brazil

 

 

 

 

The Role of Laser in Diabetic Macular Edema in the Anti-VEGF Era

Victor Chong, MD, FRCS, FRCO
UK

 

 

577 nm MicroPulse Phototherapy for Dry Risk Age Related Macular Degeneration

Joshua Morrison-Reyes, MD
Washington, DC

 

 

 

Fovea-Friendly™* MicroPulse™ Laser

Three case studies outlining parameters and technique to effectively treat DME patients.

pdf  Download Now 

 

DME - First Line Therapy - IQ 532™

Case study using IQ 532 with MicroPulse™ technology to effectively treat a 70-year-old patient with longstanding DM.

pdf  Download Now

 

DME Refractive to Avatin and Ozurdex - IQ 532™

Case study using IQ 532 with MicroPulse™ technology to effectively treat a 63-year-old patient with longstanding DM and PDR with DME.

pdf  Download Now

 

DME Refractive to 6 Injections of Bevacizumab - IQ 532™

Difficult case of diffuse diabetic macular edema who received 6 monthly injections of bevacizumab with no results.

pdf  Download Now

 

DME Refractive to 7 Injections of Bevacizumab - IQ 532™

Female patient with difficult case of diffuse DME who received 7 monthly injections of bevacizumab with no results.

pdf  Download Now

 

Diabetic Macular Edema - IQ 577™

Treatment Parameters - 577nm wavelength, 100um spot size on SLA, Macular Area Certralis contact lens, 200ms duration, 5% duty cycle

pdf  Download Now

 

Diabetic Macular Edema - IQ 532™

Case Report - 28-year-old male with type 1 diabetes, previously treated with argon focal/grid laser in February 2006 and July 2008.

pdf  Download Now

 

532 nm Subthreshold MicroPulse Effectively Reduces Diabetic Macular Edema after Failed Conventional Laser Treatment

This case involves a 75-year-old pseudophakic woman with Type 2 diabetes mellitus. Her left eye was treated in 2004 and 2008 with traditional focal laser treatment, which partially resolved her diabetic macular edema (DME).

pdf  Download Now

 

Diabetic Macular Edema - IQ 810™

Treatment Parameters - 810nm wavelength, 125um spot size on SLA, Mainster Macular Certralis contact lens, 300ms duration, 5% duty cycle

pdf  Download Now

 

Diabetic Macular Edema - IQ 577™

Case study using IQ 577 with MicroPulse™ technology to effectively treat a 69-year-old, female with Type-2 diabetes..

pdf  Download Now

 

MicroPulse™ Laser Therapy of DME Successful in Anti-VEGF Non-responder

Case study using IQ 577 with MicroPulse™ technology to effectively treat a DME patient without laser burns and collateral effect.

pdf  Download Now

“The IQ 577 produces less collateral damage than a traditional green-wavelength laser during the treatment of macular edema. It’s more efficient and increases patient comfort for panretinal photocoagulation.”

Dr. Jonathan Walker, Fort Wayne, IN


“The IQ 577 has simplified and improved the efficiency of laser clinics dramatically.”

Dr. Christopher Riemann, Cincinnati, OH


“The IQ 577 yellow laser is one such promising advancement for the treatment of macular edema secondary to BRVO.”

Drs. Sviatoslav Suk & Stanislav Saksonov, Kiev, Ukraine

logo aa0 logo ags logo ascrs logo asrs logo esrs0 logo euretina



*Bhagat N, Zarbin M, Mansour S, Chong V, and Cardillo JA. Fovea-friendly MicroPulse Laser. Supplement to Retina Today, May/June 2012

 Products

Lasers
Delivery Devices
Retina Consumables
Glaucoma Device

Resources

Physician Information
Patient Information
MicroPulse Forum
Clinical Library

 

About IRIDEX

Overview
News
Events
Contact Us

Company

Investors
Offices/Contact
Careers

twitter facebook linkedin youtuber
Copyright ©2003-2013 by IRIDEX Corporation
Terms Of Use | Privacy Statement